Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Associations of Homer Scaffolding Protein 1 gene and psychological correlates with suicide attempts in Chinese: A pilot study of multifactorial risk model.

Rao S, Siu CO, Shi M, Zhang J, Lam MHB, Yu M, Wing YK, Waye MMY.

Gene. 2018 Dec 30;679:382-388. doi: 10.1016/j.gene.2018.09.025. Epub 2018 Sep 13.

PMID:
30219717
2.

Associations of the serotonin transporter promoter polymorphism (5-HTTLPR) with bipolar disorder and treatment response: A systematic review and meta-analysis.

Rao S, Han X, Shi M, Siu CO, Waye MMY, Liu G, Wing YK.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:214-226. doi: 10.1016/j.pnpbp.2018.08.035. Epub 2018 Sep 11.

PMID:
30217771
3.

TO THE EDITOR.

Kroeger CM, Allison DB, Thomas DM, Siu CO.

Spine (Phila Pa 1976). 2018 Apr 15;43(8):E492-E493. doi: 10.1097/BRS.0000000000002564. No abstract available.

5.

Regression to the mean, apparent data errors and biologically extraordinary results: letter regarding 'changes in telomere length 3-5 years after gastric bypass surgery'.

Smith DL Jr, Thomas DM, Siu CO, Verhulst S, Allison DB.

Int J Obes (Lond). 2018 Apr;42(4):949-950. doi: 10.1038/ijo.2017.298. Epub 2017 Dec 12. No abstract available.

6.

Letter to the editor.

Halliday TM, Thomas DM, Siu CO, Allison DB.

J Women Aging. 2018 Jan-Feb;30(1):2-5. doi: 10.1080/08952841.2017.1407575. No abstract available.

7.

Change in daytime sleepiness and cognitive function in a 6-month, double-blind study of lurasidone and quetiapine XR in patients with schizophrenia.

Harvey PD, Siu CO, Loebel AD.

Schizophr Res Cogn. 2016 Jun 2;5:7-12. doi: 10.1016/j.scog.2016.05.002. eCollection 2016 Sep.

8.

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.

Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJ, Birnbaum ML, Bloomfield MA, Bressan RA, Buchanan RW, Carpenter WT, Castle DJ, Citrome L, Daskalakis ZJ, Davidson M, Drake RJ, Dursun S, Ebdrup BH, Elkis H, Falkai P, Fleischacker WW, Gadelha A, Gaughran F, Glenthøj BY, Graff-Guerrero A, Hallak JE, Honer WG, Kennedy J, Kinon BJ, Lawrie SM, Lee J, Leweke FM, MacCabe JH, McNabb CB, Meltzer H, Möller HJ, Nakajima S, Pantelis C, Reis Marques T, Remington G, Rossell SL, Russell BR, Siu CO, Suzuki T, Sommer IE, Taylor D, Thomas N, Üçok A, Umbricht D, Walters JT, Kane J, Correll CU.

Am J Psychiatry. 2017 Mar 1;174(3):216-229. doi: 10.1176/appi.ajp.2016.16050503. Epub 2016 Dec 6. Review.

9.

Efficacy of Auditory Processing-Focused Cognitive Remediation Therapy.

Siu CO, Agid O.

J Clin Psychiatry. 2016 Oct;77(10):e1352. doi: 10.4088/JCP.16lr10887. No abstract available.

10.

Insight and subjective measures of quality of life in chronic schizophrenia.

Siu CO, Harvey PD, Agid O, Waye M, Brambilla C, Choi WK, Remington G.

Schizophr Res Cogn. 2015 Sep 1;2(3):127-132. Epub 2015 Jun 9.

11.

Effect of lurasidone dose on cognition in patients with schizophrenia: post-hoc analysis of a long-term, double-blind continuation study.

Harvey PD, Siu CO, Ogasa M, Loebel A.

Schizophr Res. 2015 Aug;166(1-3):334-8. doi: 10.1016/j.schres.2015.06.008. Epub 2015 Jun 24.

12.

Measuring the effects of treatment with antipsychotics.

Siu CO, Agid O, Remington G.

JAMA Psychiatry. 2015 May;72(5):514-5. doi: 10.1001/jamapsychiatry.2014.3134. No abstract available.

PMID:
25945491
13.

Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia.

Loebel AD, Siu CO, Cucchiaro JB, Pikalov AA, Harvey PD.

CNS Spectr. 2014 Apr;19(2):197-205. doi: 10.1017/S1092852913000904. Epub 2013 Dec 13.

14.

Efficacy of antipsychotic drugs for schizophrenia.

Siu CO, Agid O, Remington G.

Lancet. 2013 Dec 7;382(9908):1874. doi: 10.1016/S0140-6736(13)62616-1. No abstract available.

PMID:
24315169
15.

Effect of lurasidone on neurocognitive performance in patients with schizophrenia: a short-term placebo- and active-controlled study followed by a 6-month double-blind extension.

Harvey PD, Siu CO, Hsu J, Cucchiaro J, Maruff P, Loebel A.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1373-82. doi: 10.1016/j.euroneuro.2013.08.003. Epub 2013 Aug 27.

PMID:
24035633
16.

Meta-regression analysis of placebo response in antipsychotic trials, 1970-2010.

Agid O, Siu CO, Potkin SG, Kapur S, Watsky E, Vanderburg D, Zipursky RB, Remington G.

Am J Psychiatry. 2013 Nov;170(11):1335-44. doi: 10.1176/appi.ajp.2013.12030315.

PMID:
23896810
17.

Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial.

Fleischhacker WW, Siu CO, Bodén R, Pappadopulos E, Karayal ON, Kahn RS; EUFEST study group.

Int J Neuropsychopharmacol. 2013 Jun;16(5):987-95. doi: 10.1017/S1461145712001241. Epub 2012 Dec 20.

PMID:
23253821
18.

Early prediction of clinical and functional outcome in schizophrenia.

Agid O, Siu CO, Pappadopulos E, Vanderburg D, Remington G.

Eur Neuropsychopharmacol. 2013 Aug;23(8):842-51. doi: 10.1016/j.euroneuro.2012.10.005. Epub 2012 Nov 7.

PMID:
23141372
19.

Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles.

Kemp DE, Karayal ON, Calabrese JR, Sachs GS, Pappadopulos E, Ice KS, Siu CO, Vieta E.

Eur Neuropsychopharmacol. 2012 Feb;22(2):123-31. doi: 10.1016/j.euroneuro.2011.06.005. Epub 2011 Jul 28.

20.

A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial.

Stahl SM, Malla A, Newcomer JW, Potkin SG, Weiden PJ, Harvey PD, Loebel A, Watsky E, Siu CO, Romano S.

J Clin Psychopharmacol. 2010 Aug;30(4):425-30. doi: 10.1097/JCP.0b013e3181e69042. Erratum in: J Clin Psychopharmacol. 2010 Oct;30(5):652.

PMID:
20571437
21.

Understanding the relationship between baseline BMI and subsequent weight change in antipsychotic trials: effect modification or regression to the mean?

Allison DB, Loebel AD, Lombardo I, Romano SJ, Siu CO.

Psychiatry Res. 2009 Dec 30;170(2-3):172-6. doi: 10.1016/j.psychres.2008.10.007. Epub 2009 Nov 8.

PMID:
19897253
22.

Dropouts and missing data in psychiatric clinical trials.

Potkin SG, Siu CO.

Am J Psychiatry. 2009 Nov;166(11):1295; author reply 1295-6. doi: 10.1176/appi.ajp.2009.09070959. No abstract available.

PMID:
19884237
23.

Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission.

Ketter TA, Agid O, Kapur S, Loebel A, Siu CO, Romano SJ.

J Psychiatr Res. 2010 Jan;44(1):8-14. doi: 10.1016/j.jpsychires.2009.07.006. Epub 2009 Aug 21.

PMID:
19699488
24.

Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol.

Potkin SG, Weiden PJ, Loebel AD, Warrington LE, Watsky EJ, Siu CO.

Int J Neuropsychopharmacol. 2009 Oct;12(9):1233-48. doi: 10.1017/S1461145709000352. Epub 2009 May 7.

PMID:
19419595
25.

Interpreting T scores and percentile equivalents using the MATRICS consensus cognitive battery in schizophrenia trials.

Siu CO.

Am J Psychiatry. 2008 Jul;165(7):914; author reply 914-5. doi: 10.1176/appi.ajp.2008.08030379. No abstract available.

PMID:
18593789
26.

Ziprasidone in treatment-resistant schizophrenia: a 52-week, open-label continuation study.

Loebel AD, Khanna S, Rajadhyaksha S, Siu CO, Giller E, Potkin SG.

J Clin Psychiatry. 2007 Sep;68(9):1333-8.

PMID:
17915970
27.

Effects of normal aging on left ventricular lusitropic, inotropic, and chronotropic responses to dobutamine.

Hees PS, Fleg JL, Mirza ZA, Ahmed S, Siu CO, Shapiro EP.

J Am Coll Cardiol. 2006 Apr 4;47(7):1440-7. Epub 2006 Mar 20.

28.

Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia.

Simpson GM, Weiden P, Pigott T, Murray S, Siu CO, Romano SJ.

Am J Psychiatry. 2005 Aug;162(8):1535-8.

PMID:
16055779
29.
32.

MRI assessment of LV relaxation by untwisting rate: a new isovolumic phase measure of tau.

Dong SJ, Hees PS, Siu CO, Weiss JL, Shapiro EP.

Am J Physiol Heart Circ Physiol. 2001 Nov;281(5):H2002-9.

33.

A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis.

Adelglass J, Jones TM, Ruoff G, Kahn JB, Wiesinger BA, Rielly-Gauvin K, Siu CO.

Pharmacotherapy. 1998 Nov-Dec;18(6):1255-63.

PMID:
9855324
34.

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy.

Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, Donofrio P, Cornblath D, Sachdeo R, Siu CO, Kamin M.

Neurology. 1998 Jun;50(6):1842-6.

PMID:
9633738
35.

Noninvasive measurement of shortening in the fiber and cross-fiber directions in the normal human left ventricle and in idiopathic dilated cardiomyopathy.

MacGowan GA, Shapiro EP, Azhari H, Siu CO, Hees PS, Hutchins GM, Weiss JL, Rademakers FE.

Circulation. 1997 Jul 15;96(2):535-41.

PMID:
9244222
36.

Effects of afterload on regional left ventricular torsion.

MacGowan GA, Burkhoff D, Rogers WJ, Salvador D, Azhari H, Hees PS, Zweier JL, Halperin HR, Siu CO, Lima JA, Weiss JL, Shapiro EP.

Cardiovasc Res. 1996 Jun;31(6):917-25.

PMID:
8759247
37.

Frequency of hypoxanthine guanine phosphoribosyltransferase (HPRT-) T cells in the peripheral blood of cardiac transplant recipients. A noninvasive technique for the diagnosis of allograft rejection.

Ansari AA, Mayne A, Sundstrom JB, Gravanis MB, Kanter K, Sell KW, Villinger F, Siu CO, Herskowitz A.

Circulation. 1995 Aug 15;92(4):862-74.

PMID:
7641367
38.

A noninvasive comparative study of myocardial strains in ischemic canine hearts using tagged MRI in 3-D.

Azhari H, Weiss JL, Rogers WJ, Siu CO, Shapiro EP.

Am J Physiol. 1995 May;268(5 Pt 2):H1918-26.

PMID:
7771541
39.

Different effects of fosinopril and atenolol on wave reflections in hypertensive patients.

Chen CH, Ting CT, Lin SJ, Hsu TL, Yin FC, Siu CO, Chou P, Wang SP, Chang MS.

Hypertension. 1995 May;25(5):1034-41.

PMID:
7737712
40.

Relation of regional cross-fiber shortening to wall thickening in the intact heart. Three-dimensional strain analysis by NMR tagging.

Rademakers FE, Rogers WJ, Guier WH, Hutchins GM, Siu CO, Weisfeldt ML, Weiss JL, Shapiro EP.

Circulation. 1994 Mar;89(3):1174-82.

PMID:
8124804
41.

Variability in measures of coronary lumen dimensions using quantitative coronary angiography.

Herrington DM, Siebes M, Sokol DK, Siu CO, Walford GD.

J Am Coll Cardiol. 1993 Oct;22(4):1068-74.

42.

Noninvasive quantification of principal strains in normal canine hearts using tagged MRI images in 3-D.

Azhari H, Weiss JL, Rogers WJ, Siu CO, Zerhouni EA, Shapiro EP.

Am J Physiol. 1993 Jan;264(1 Pt 2):H205-16.

PMID:
8430847
43.

Clinical predictors of myocardial damage after high voltage electrical injury.

Chandra NC, Siu CO, Munster AM.

Crit Care Med. 1990 Mar;18(3):293-7.

PMID:
2302956
44.

Relative importance of four pressoregulatory mechanisms after 10% bleeding in rabbits.

Katoh N, Sheriff DD, Siu CO, Sagawa K.

Am J Physiol. 1989 Jan;256(1 Pt 2):H291-6.

PMID:
2912191
45.

Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm.

Shapiro EP, Effron MB, Lima S, Ouyang P, Siu CO, Bush D.

Am J Cardiol. 1988 Dec 1;62(17):1202-7.

PMID:
3195481
46.

Nausea and vomiting during acute myocardial infarction and its relation to infarct size and location.

Herlihy T, McIvor ME, Cummings CC, Siu CO, Alikahn M.

Am J Cardiol. 1987 Jul 1;60(1):20-2.

PMID:
3604939
47.

Augmentation of pressure in a vessel indenting the surface of the lung.

Tsitlik JE, Halperin HR, Guerci AD, Dvorine LS, Popel AS, Siu CO, Yin FC, Weisfeldt ML.

Ann Biomed Eng. 1987;15(3-4):259-84.

PMID:
3662147
48.

The cellular electrophysiologic changes induced by high-energy electrical ablation in canine myocardium.

Levine JH, Spear JF, Weisman HF, Kadish AH, Prood C, Siu CO, Moore EN.

Circulation. 1986 Apr;73(4):818-29.

PMID:
3948378

Supplemental Content

Support Center